Which small biotech AI company is Jeff Brown referring to?Who knows which small cap company Jeff Brown is referring to as causing the next “convergence”?
According to him the small cap company’s Artifical Intelligence can evaluate 2 billion molecules per week in searching for drugs to cure several life-threatening diseases, such as for example pancreatic cancer. He mentions that Bill Gates has invested $300 million in this small cap company.
Thanks for your thoughts.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
I just did some further searching and thought that it might be ‘Atomwise’, but didn’t see any mention on their website about a partnership with Bristol-Myers Squibb that Jeff Brown mentioned. So, I guess it must be another small cap company in this field, although the way Atomwise describes itzelf (e.g.: “Atomwise is revolutionizing how drugs are discovered with AI.”) fits part of the profile painted by Jeff Brown..
I think its ” Insilico Medicine”
https://www.medidata.com/
as near as i can tell, this MIGHT be the company he is talking about. Its part of Dassault Systemes which appears to be what you would buy shares of to get in on this. Ticker DASD
It’s Schrodinger Inc. I found the answer on another website.
More detail here, FYI: https://www.stockgumshoe.com/reviews/exponential-tech-investor/convergence-company-taking-over-biotech-whats-jeff-browns-small-cap-company-using-ai-to-discover-drugs/
Thank you to those answering – I just found this as I was curious too. I have to admit to being torn on this. I think AI is moving too fast and do I want to support that. ON the other hand, it is going to happen regardless of whether I invest or not. genuinely torn.